{
  "ticker": "JNJ",
  "target_date": "2025-06-25",
  "actual_date": "2025-06-25",
  "collected_at": "2025-12-08T11:56:09.902480",
  "price": {
    "open": 149.33,
    "high": 151.0,
    "low": 148.69,
    "close": 150.21664428710938,
    "volume": 7153700,
    "change_1d_pct": 0.06,
    "change_7d_pct": -3.07,
    "change_30d_pct": -0.36
  },
  "technicals": {
    "rsi_14": 47.07,
    "sma_20": 151.79,
    "sma_50": 151.15,
    "macd": -0.382,
    "macd_signal": -0.003,
    "macd_histogram": -0.379,
    "bb_upper": 155.83,
    "bb_lower": 147.76,
    "price_vs_sma20_pct": -1.04,
    "price_vs_sma50_pct": -0.62,
    "volume_ratio": 0.87
  },
  "fundamentals": {
    "market_cap": 489123053568,
    "pe_ratio": 19.596043,
    "forward_pe": 19.152357,
    "price_to_book": 6.161866,
    "price_to_sales": 5.3079586,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.31,
    "pct_from_52w_low": 44.31
  },
  "macro": {
    "spy": {
      "price": 605.44,
      "change_1d_pct": 0.06,
      "change_7d_pct": 1.03
    },
    "vix": {
      "level": 16.76,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.29
    },
    "dollar_index": {
      "level": 97.68
    },
    "gold": {
      "price": 3327.1
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial",
      "source": "Yahoo",
      "datetime": 1750878521,
      "summary": "Johnson & Johnson (NYSE:JNJ) ranks among the top stocks for an early retirement portfolio. On June 13, Johnson & Johnson (NYSE:JNJ) announced that patients with relapsed or refractory large B-cell lymphoma (LBCL) showed strong response rates to its investigational dual-targeting CAR T-cell treatment",
      "url": "https://finnhub.io/api/news?id=36fea0d1735375f09e80422267b33dcc1991407fcdcaf9e83f2a92ac0be9199b"
    },
    {
      "headline": "6 Stocks to Buy to Give Your Portfolio the Perfect Mix of Growth, Value, and Defense",
      "source": "Yahoo",
      "datetime": 1750851002,
      "summary": "This blend of stocks may be the key to long-term success.",
      "url": "https://finnhub.io/api/news?id=e8e4bd9547263b5ff0c399fc0b71af3b6ec2ca1cb2055572ca6975e97508a991"
    },
    {
      "headline": "Regeneron Pharmaceuticals Stock May Be Worth Buying Again - Rating Upgrade",
      "source": "SeekingAlpha",
      "datetime": 1750843166,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a3823b4eab8a3b599bb3f96eadd46ece5ce0a8a1b93cde82204d858cec42fb25"
    },
    {
      "headline": "Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US",
      "source": "Yahoo",
      "datetime": 1750840177,
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 Best and Cheap Stocks to Buy Now. On June 19, Johnson & Johnson (NYSE:JNJ) announced the launch of two new plating systems in the United States under its VOLT platform, called Distal Radius and Proximal Humerus 3.5 Plating Systems. The systems are design",
      "url": "https://finnhub.io/api/news?id=4f9cdd5316a0c11e841decbfb59986ebc551facff860bb673f765167ab88a238"
    },
    {
      "headline": "My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys",
      "source": "SeekingAlpha",
      "datetime": 1750839000,
      "summary": "Explore May 2025 market volatility, U.S.-China trade talks, and record dividend income growth.",
      "url": "https://finnhub.io/api/news?id=28d3b832c1fca31770119594903f09760ded636b8898fcc7533e46ddeeaa3cac"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760229.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/xslF345X05/wk-form4_1749760229.xml"
    },
    {
      "form": "8-K",
      "date": "2025-06-10",
      "description": "jnj-20250610.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/jnj-20250610.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}